Idenix Pharm (IDIX)
Idenix Pharmaceuticals, Inc. is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and Europe. The company's research and development focus is on the treatment of hepatitis C virus (HCV). In July 2009, the company completed the proof-of-concept clinical trial in treatment-naive HCV genotype I infected patients. In October 2009, it initiated a 14-day dose-ranging phase IIa clinical trial evaluating IDX184 in combination with pegylated interferon and ribavirin in treatment-naive HCV genotype I infected patients. Idenix selected IDX320 as its lead clinical candidate from its...
read more
Contact Information:
| Business Address: | - |
| Mailing Address: | 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800 IDENIX PHARMACEUTICALS INC CIK #: 00010 |
| Phone: | 617-995-9800 |
| Fax: | 617-995-9801 |
| Website: | http://www.idenix.com |
Company Details:
| Symbol: | IDIX |
| SIC: | - |
| State location: | MA |
| Sector: | - |
| State of Inc: | DE |
| Employees: | 144 |
| Type: | NASDAQ |
Key executives:
| Name | Age | Position |
|---|---|---|
| Andrea J. Corcoran | 50 | Advisor |
| David A. Arkowitz | 51 | Chief Financial Officer, Principal Accounting Officer and Treasurer |
| Douglas Mayers M.D. | - | Exec. VP and Chief Medical Officer |
| Guy MacDonald | 53 | Exec. VP of Operations |
| Jean-Pierre Sommadossi Ph.D. | 56 | Founder, Chairman, Chief Exec. Officer and Pres |
Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) Marks One More High Before the Call Jul 26, 2010
The per-earnings release mood overrode Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) as well and as the mood was obviously optimistic, the stock made one of the biggest increases in its industry on Friday. With the 52-week high being updated once again, the earnings call will have to bring milestone results today.read more
| Post # | Subject | Re | Name | Date |
|---|---|---|---|---|
| 1 | The stock price has changed since... | 0 | Eugene | August 19, 2008, 02:05AM |
| 2 | Here on this message board we are inviting... | 0 | Guest | August 19, 2008, 02:05AM |

